Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
Sign Up to like & getrecommendations! Published in 2021 at "Lung"
DOI: 10.1007/s00408-021-00437-7
Abstract: This analysis assesses clinical characteristics of patients with refractory chronic cough (RCC) or unexplained chronic cough (UCC) enrolled in a phase 2 study to better understand this patient population. Patients with RCC/UCC lasting for ≥ 1 year… read more here.
Keywords: phase; unexplained chronic; cough; patients refractory ... See more keywords
How should we manage women with unexplained chronic pelvic pain in light of uncertainty about the effectiveness of gabapentin?
Sign Up to like & getrecommendations! Published in 2017 at "British Medical Journal"
DOI: 10.1136/bmj.j3624
Abstract: Chronic pelvic pain affects 2.1% to 24% of the global female population,12 and up to half of the affected women have no obvious pathology.23 The neuromodulator gabapentin can be used to modulate pain, but the… read more here.
Keywords: pelvic pain; unexplained chronic; pain; manage women ... See more keywords